Sign inGet started

HURLY STEPHEN A

Insider CIK 1130637 · EBIO President and CEO, Director · LVTX Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LVTX LAVA Therapeutics NV D To issuer deriv2025-11-132025-11-17335,100— $00SEC↗
LVTX LAVA Therapeutics NV D To issuer2025-11-132025-11-175,000— $00SEC↗
LVTX LAVA Therapeutics NV A Award deriv2025-02-132025-02-18335,100— $0335,100SEC↗
SESN Sesen Bio, Inc. A Award deriv2018-06-122018-06-1487,150— $0272,580SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2018-04-092018-04-11250,000— $0250,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2018-03-142018-03-16105,000— $0105,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2018-01-182018-01-2280,430— $080,430SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2017-04-032017-04-0532,692— $032,692SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-09-202016-09-22350,000— $0350,000SEC↗
EBIO Eleven Biotherapeutics, In A Award2016-09-202016-09-22398,031— $0398,031SEC↗